Clene Inc. (CLNN) financial statements (2022 and earlier)

Company profile

Business Address 6550 SOUTH MILLROCK DRIVE, SUITE G50
SALT LAKE CITY, UT 84121
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments50,34659,275
Cash and cash equivalents50,34659,275
Receivables49 
Inventory, net of allowances, customer advances and progress billings41191
Inventory41191
Other undisclosed current assets4,1473,523
Total current assets:54,58362,989
Noncurrent Assets
Operating lease, right-of-use asset3,2501,029
Property, plant and equipment5,1724,225
Restricted cash and investments58 
Total noncurrent assets:8,4805,254
TOTAL ASSETS:63,06368,243
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:3,6103,960
Accounts payable 1,124
Accrued liabilities 3,960
Employee-related liabilities2,0821,258
Taxes payable 164
Other undisclosed accounts payable and accrued liabilities1,528(2,546)
Deferred revenue 112
Debt1466,114
Other undisclosed current liabilities2,2701,482
Total current liabilities:6,02611,668
Noncurrent Liabilities
Long-term debt and lease obligation18,9513,939
Long-term debt, excluding current maturities14,4841,949
Finance lease, liability97205
Operating lease, liability4,3701,785
Liabilities, other than long-term debt18,100260
Deferred income tax liabilities 260
Derivative instruments and hedges, liabilities18,100 
Other undisclosed noncurrent liabilities7,38952,035
Total noncurrent liabilities:44,44056,234
Total liabilities:50,46667,902
Stockholders' equity
Stockholders' equity attributable to parent12,597341
Common stock66
Additional paid in capital175,659153,571
Accumulated other comprehensive income233325
Accumulated deficit(163,301)(153,561)
Total stockholders' equity:12,597341
TOTAL LIABILITIES AND EQUITY:63,06368,243

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
Revenues723206
Revenue from related parties500 
Gross profit:723206
Operating expenses(50,701)(20,420)
Operating loss:(49,978)(20,214)
Nonoperating income39,8101,343
Interest and debt expense648(540)
Loss from continuing operations before equity method investments, income taxes:(9,520)(19,411)
Other undisclosed income (loss) from continuing operations before income taxes(648)540
Loss from continuing operations before income taxes:(10,168)(18,871)
Income tax expense (benefit)428(406)
Net loss available to common stockholders, diluted:(9,740)(19,277)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
Net loss:(9,740)(19,277)
Other comprehensive income (loss)(92)284
Comprehensive loss, net of tax, attributable to parent:(9,832)(18,993)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: